We found that both GLUT1 and GLUT2 were significantly increased in cancer tissues and their expressions were correlated with clinical stage (GLUT1, p < 0.001; GLUT2, p = 0.001) (Fig. S1A–B). Here, SLC2A1 is linked to cancer.